Alerts will be sent to your verified email
Verify Email
SUPRIYA
|
Supriya Lifescience
|
Acutaas Chemicals
|
Aether Industries
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
23.4 % | 15.72 % | 12.44 % |
|
5yr average Equity Multiplier
|
1.25 | 1.57 | 1.36 |
|
5yr Average Asset Turnover Ratio
|
0.68 | 0.74 | 0.45 |
|
5yr Avg Net Profit Margin
|
25.52 % | 12.98 % | 17.79 % |
|
Price to Book
|
5.55 | 9.89 | 4.82 |
|
P/E
|
32.91 | 62.42 | 57.65 |
|
5yr Avg Cash Conversion Cycle
|
-10.96 Days | 55.02 Days | 173.8 Days |
|
Inventory Days
|
56.1 Days | 64.12 Days | 139.35 Days |
|
Days Receivable
|
57.43 Days | 90.06 Days | 113.43 Days |
|
Days Payable
|
113.66 Days | 127.33 Days | 100.34 Days |
|
5yr Average Interest Coverage Ratio
|
60.74 | 25.42 | 19.69 |
|
5yr Avg ROCE
|
30.51 % | 20.01 % | 15.21 % |
|
5yr Avg Operating Profit Margin
|
36.15 % | 20.92 % | 26.99 % |
|
5 yr average Debt to Equity
|
0.06 | 0.23 | 0.23 |
|
5yr CAGR Net Profit
|
8.75 % | 24.06 % | 7.78 % |
|
5yr Average Return on Assets
|
17.81 % | 9.8 % | 8.26 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
68.3 % | 32.66 % | 75.0 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.06 % | -6.75 % | -12.09 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-1.7 % | 12.5 % | 4.44 % |
|
Supriya Lifescience
|
Acutaas Chemicals
|
Aether Industries
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|